JAMES L L TULLIS

CIK 1230641 · last filed 2026-06-01

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$28.34M

Companies

7

Total Filings

103

Lifetime Open-Market Net

-$8.42M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CR Director 6,449 $206.57 $1.33M $0 8 2026-06-01
CXT Director 9,960 $42.47 $423.0K $0 9 2026-05-26
ATEC Director 797,893 $8.28 $6.61M -$7.83M 20 2023-09-13
XGN Director 25,885 $4.67 $120.9K -$1.80M 20 2022-06-21
ECOR Director 1,937,209 $10.25 $19.86M $1.59M 5 2020-04-16
INTERPHARM HOLDINGS INC (IPA) Delisted 10%+ Owner $2.07 $0 1 2008-02-29
VIACELL INC (VIAC) Delisted Director 1,753,221 $29.58 $51.86M -$375.0K 2 2007-01-29

Recent Filings · Page 11 of 11

103 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2007-04-25 Grant (A) $0
2007-01-29 VIACELL INC (VIAC) Delisted Mixed +187,437 -$3 EDGAR
2007-01-22 VIACELL INC (VIAC) Delisted Other (J) −500,000 $0 EDGAR
Showing 101103 of 103
Page 11 of 11
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.